Invirsa, Inc.
Clinical trials sponsored by Invirsa, Inc., explained in plain language.
-
Eye drops could replace needles for diabetic vision loss?
Disease control CompletedThis early-phase study tested whether INV-102 eye drops can help control diabetic macular edema, a condition that causes vision loss in people with diabetes. Nineteen adults with non-proliferative diabetic retinopathy used the drops daily for 8 to 12 weeks. The goal was to see if…
Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New eye drops aim to quench dry eye discomfort
Symptom relief CompletedThis study tested an experimental eye drop called INV-102 in 84 adults with moderate dry eye disease. The goal was to check safety and see if it reduces eye dryness. Participants used the drops for two weeks, and researchers measured changes in dryness symptoms.
Phase: PHASE1, PHASE2 • Sponsor: Invirsa, Inc. • Aim: Symptom relief
Last updated May 26, 2026 12:03 UTC